MARSHALL & POPP, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical manufacturer.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Jul 21, 2025

Bills named in this filing 3

S 475
Alternatives to PAIN Act
HR 1227
Alternatives to PAIN Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Medicare/Medicaid

Issues related to pain management, including S.475/H.R. 1227 - Alternatives to PAIN Act. H.R. 1, FY25 budget reconciliation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.